Lévi F - Search Results

1

Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.

Efficace F, Innominato PF, Bjarnason G, Coens C, Humblet Y, Tumolo S, Genet D, Tampellini M, Bottomley A, Garufi C, Focan C, Giacchetti S, Lévi F; Chronotherapy Group of the European Organisation for Research and Treatment of Cancer. Efficace F, et al. Among authors: levi f. J Clin Oncol. 2008 Apr 20;26(12):2020-6. doi: 10.1200/JCO.2007.12.3117. J Clin Oncol. 2008. PMID: 18421055 Clinical Trial.

2

Chronomodulation of chemotherapy against metastatic colorectal cancer. International Organization for Cancer Chronotherapy.

Lévi F, Giacchetti S, Adam R, Zidani R, Metzger G, Misset JL. Lévi F, et al. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1264-70. doi: 10.1016/0959-8049(95)00242-b. Eur J Cancer. 1995. PMID: 7577034 Review.

3

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.

Lévi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, Chollet P, Garufi C, Itzhaki M, Dogliotti L, et al. Lévi FA, et al. J Natl Cancer Inst. 1994 Nov 2;86(21):1608-17. doi: 10.1093/jnci/86.21.1608. J Natl Cancer Inst. 1994. PMID: 7932825 Clinical Trial.

4

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate.

Levi F, Perpoint B, Garufi C, Focan C, Chollet P, Depres-Brummer P, Zidani R, Brienza S, Itzhaki M, Iacobelli S, et al. Levi F, et al. Eur J Cancer. 1993;29A(9):1280-4. doi: 10.1016/0959-8049(93)90073-o. Eur J Cancer. 1993. PMID: 8343268 Clinical Trial.

5

Ambulatory treatment with 5 days continuous venous infusion of ifosfamide for advanced colorectal cancer: a phase II feasibility study.

Focan C, Kreutz F, Levi F. Focan C, et al. Among authors: levi f. Anticancer Drugs. 1993 Aug;4(4):459-62. doi: 10.1097/00001813-199308000-00006. Anticancer Drugs. 1993. PMID: 8400348 Clinical Trial.

6

Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study.

Garufi C, Lévi F, Giunta S, Aschelter A, Pace R, Nisticò C, Terzoli E. Garufi C, et al. Among authors: levi f. J Infus Chemother. 1995;5(3 Suppl 1):134-7. J Infus Chemother. 1995. PMID: 8528973 Clinical Trial.

7

Ambulatory chronotherapy with 5-fluorouracil, folinic acid, and carboplatin for advanced non-small cell lung cancer. A phase II feasibility trial.

Focan C, Denis B, Kreutz F, Focan-Henrard D, Levi F. Focan C, et al. Among authors: levi f. J Infus Chemother. 1995;5(3 Suppl 1):148-52. J Infus Chemother. 1995. PMID: 8528976 Clinical Trial.

8

Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer.

Bertheault-Cvitkovic F, Jami A, Ithzaki M, Brummer PD, Brienza S, Adam R, Kunstlinger F, Bismuth H, Misset JL, Lévi F. Bertheault-Cvitkovic F, et al. Among authors: levi f. J Clin Oncol. 1996 Nov;14(11):2950-8. doi: 10.1200/JCO.1996.14.11.2950. J Clin Oncol. 1996. PMID: 8918492 Clinical Trial.

9

A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer.

Garufi C, Lévi F, Aschelter AM, Pace R, Giunta S, Nisticò C, Gallà DA, Silecchia GF, Franchi F, Narduzzi C, Terzoli E. Garufi C, et al. Among authors: levi f. Eur J Cancer. 1997 Sep;33(10):1566-71. doi: 10.1016/s0959-8049(97)00133-0. Eur J Cancer. 1997. PMID: 9389916 Clinical Trial.

10

Tumori. Chronotherapy Study Group of the European Organization for Research and Treatment of Cancer.

Garufi C, Dogliotti L, Terzoli E, Focan C, Smaaland R, Chollet P, Perpoint B, Lévi F. Garufi C, et al. Among authors: levi f. Tumori. 1999 Mar-Apr;85(2):149-50. Tumori. 1999. PMID: 10363085 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

963 results

Search Page

Filters